Panacea Biotec Q4 Results

  • BSE: 531349
  • NSE: PANACEABIO
  • ISIN: INE922B01023
  • Sector: Biotechnology & Drugs
BSE
421.4512.00 (2.93%)
Volume15.20 K
Updated: Mon 25 Nov, 2024 | 15:52:39
NSE
426.216.20 (3.95%)
Volume2.42 L
Updated: Mon 25 Nov, 2024 | 15:31:25
Today: 404.00
428.00
52-Wk: 112.70
420.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Panacea Biotec Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 136.46115.20-%128.93-%
    Selling/ General/ Admin Expenses Total 38.4332.02-%30.55-%
    Depreciation/ Amortization 8.81--%35.73-%
    Other Operating Expenses Total 54.3227.49-%46.56-%
    Total Operating Expense 148.5779.52-%150.95-%
    Operating Income -12.1135.68-%-22.02-%
    Net Income Before Taxes -2.1222.44-%18.21-%
    Net Income -1.4319.36-%-12.41-%
    Diluted Normalized EPS -0.520.21-%-3.95-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts